Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    22325110 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Oral Contraceptive (OC) Progestin Dose and Breast Proliferation
Condition: Oral Contraceptive
Interventions: Drug: Oral Contraceptive: Ortho-Novum® 1/35;   Drug: Oral Contraceptive: Ovcon Fe®

Indicates status has not been verified in more than two years